ZUARI.NS
Zuari Agro Chemicals Limited [ZUARI.NS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ZUARI.NS Stock Summary
Top 10 Correlated ETFs
ZUARI.NS
Top 10 Correlated Stocks
ZUARI.NS
In the News
ZUARI.NS Financial details
Company Rating
Buy
Market Cap
8.45B
Income
-4.34B
Revenue
50.36B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
624
Optionable
No
Shortable
Yes
Earnings
18 May 2024
P/E
-2.27
Forward P/E
-
PEG
0.06
P/S
0.15
P/B
0.54
P/C
-
P/FCF
-
Quick Ratio
0.55
Current Ratio
0.76
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-79.91
EPS next Y
-
EPS next Q
-
EPS this Y
265.46%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-10.88%
Revenue Q/Q
-48.82%
EPS Q/Q
-89.92%
-
-
-
-
SMA20
10.67%
SMA50
-17.57%
SMA100
26.28%
Inst Own
-
Inst Trans
-
ROA
-7%
ROE
-34%
ROC
0.22%
Gross Margin
34%
Oper. Margin
11%
Profit Margin
-7%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
127.55-258.0
52W High
-25.47%
52W Low
+51.42%
RSI
47
Rel Volume
0.44
Avg Volume
453.51K
Volume
200.28K
Perf Week
-4.85%
Perf Month
-9.55%
Perf Quarter
36.14%
Perf Half Y
20.98%
-
-
-
-
Beta
0.218
-
-
Volatility
3.97%, 13.5%
Prev Close
2.64%
Price
192.3
Change
-2.39%
ZUARI.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
| Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 1.93K | 1.19K | 571.18 | 853.11 | 1.08K | |
| Net income per share | -40.56 | -190.68 | -37.35 | 31.01 | 113.33 | |
| Operating cash flow per share | -84.34 | 626.59 | 361.66 | 135.85 | 22.54 | |
| Free cash flow per share | -119.48 | 606.19 | 342.65 | 81.71 | -52.76 | |
| Cash per share | 12.76 | 63.02 | 109.69 | 139.22 | 109.09 | |
| Book value per share | 301.97 | 81.12 | 46.65 | 87.26 | 375.95 | |
| Tangible book value per share | 367.27 | 151.32 | 124.67 | 174.33 | 476.99 | |
| Share holders equity per share | 301.97 | 81.12 | 46.65 | 87.26 | 375.95 | |
| Interest debt per share | 1.34K | 913.94 | 481.46 | 664.72 | 549.98 | |
| Market cap | 8.07B | 2.6B | 3.82B | 5.63B | 5.1B | |
| Enterprise value | 59.92B | 33.63B | 18.06B | 26.41B | 22.28B | |
| P/E ratio | -4.73 | -0.32 | -2.43 | 4.32 | 1.07 | |
| Price to sales ratio | 0.1 | 0.05 | 0.16 | 0.16 | 0.11 | |
| POCF ratio | -2.27 | 0.1 | 0.25 | 0.99 | 5.38 | |
| PFCF ratio | -1.61 | 0.1 | 0.27 | 1.64 | -2.3 | |
| P/B Ratio | 0.64 | 0.76 | 1.95 | 1.54 | 0.32 | |
| PTB ratio | 0.64 | 0.76 | 1.95 | 1.54 | 0.32 | |
| EV to sales | 0.74 | 0.67 | 0.75 | 0.74 | 0.49 | |
| Enterprise value over EBITDA | 15.43 | -26.41 | 4.73 | 6 | 4.25 | |
| EV to operating cash flow | -16.89 | 1.28 | 1.19 | 4.62 | 23.5 | |
| EV to free cash flow | -11.92 | 1.32 | 1.25 | 7.68 | -10.04 | |
| Earnings yield | -0.21 | -3.09 | -0.41 | 0.23 | 0.94 | |
| Free cash flow yield | -0.62 | 9.82 | 3.77 | 0.61 | -0.44 | |
| Debt to equity | 4.12 | 9.87 | 9.43 | 7.2 | 1.33 | |
| Debt to assets | 0.56 | 0.51 | 0.34 | 0.42 | 0.42 | |
| Net debt to EBITDA | 13.35 | -24.37 | 3.73 | 4.72 | 3.28 | |
| Current ratio | 0.91 | 0.66 | 0.66 | 0.69 | 0.81 | |
| Interest coverage | 0.78 | 0.22 | 0.81 | 1.29 | 1.37 | |
| Income quality | 2.39 | -3.58 | -17.33 | 2.62 | 0.14 | |
| Dividend Yield | 0.01 | 0.02 | 0.01 | 0.01 | 0.02 | |
| Payout ratio | -0.03 | -0.01 | -0.02 | 0.04 | 0.02 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0.01 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | |
| Capex to operating cash flow | 0.42 | -0.03 | -0.05 | -0.4 | -3.34 | |
| Capex to revenue | -0.02 | -0.02 | -0.03 | -0.06 | -0.07 | |
| Capex to depreciation | -1.69 | -0.78 | -0.75 | -3.37 | -4.03 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 524.96 | 589.95 | 198 | 246.76 | 979.1 | |
| ROIC | 0.05 | 0.03 | 0.04 | 0.05 | 0.06 | |
| Return on tangible assets | -0.02 | -0.12 | -0.03 | 0.02 | 0.1 | |
| Graham Net | -870.52 | -817.6 | -647.64 | -716.77 | -401.69 | |
| Working capital | -5.98B | -17.58B | -13.92B | -15B | -4.13B | |
| Tangible asset value | 15.45B | 6.36B | 5.24B | 7.33B | 20.06B | |
| Net current asset value | -15.08B | -23.52B | -20.34B | -21.42B | -11.43B | |
| Invested capital | 4.12 | 9.87 | 9.43 | 7.2 | 1.33 | |
| Average receivables | 40.63B | 33.14B | 21.77B | 20.02B | 14.37B | |
| Average payables | 17.33B | 19.62B | 11.87B | 4.98B | 5.35B | |
| Average inventory | 14.08B | 11.57B | 3.85B | 3.63B | 4.51B | |
| Days sales outstanding | 188.81 | 177.84 | 291.15 | 212.38 | 63.05 | |
| Days payables outstanding | 117.68 | 188.73 | 95.68 | 90.5 | 57.29 | |
| Days of inventory on hand | 106.17 | 52.66 | 51.91 | 77.67 | 47.25 | |
| Receivables turnover | 1.93 | 2.05 | 1.25 | 1.72 | 5.79 | |
| Payables turnover | 3.1 | 1.93 | 3.81 | 4.03 | 6.37 | |
| Inventory turnover | 3.44 | 6.93 | 7.03 | 4.7 | 7.72 | |
| ROE | -0.13 | -2.35 | -0.8 | 0.36 | 0.3 | |
| Capex per share | -35.14 | -20.4 | -19.01 | -54.13 | -75.3 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 336.72 | 318.35 | 286.6 | 391.84 | 200.54 | |
| Net income per share | 16.46 | -108.99 | -5.77 | 8.44 | 3.19 | |
| Operating cash flow per share | 10.62 | 10.11 | 10.85 | 0 | 11.49 | |
| Free cash flow per share | 10.62 | 10.11 | 10.85 | 0 | 11.49 | |
| Cash per share | 65.08 | 109.09 | 0 | 237.92 | 0 | |
| Book value per share | 403.97 | 375.95 | 0 | 379.03 | 0 | |
| Tangible book value per share | 0 | 476.99 | 0 | 516.62 | 0 | |
| Share holders equity per share | 403.97 | 375.95 | 0 | 379.03 | 0 | |
| Interest debt per share | 13.22 | 513.86 | 13.44 | 430.23 | 11.6 | |
| Market cap | 6.89B | 5.1B | 6.22B | 6.55B | 8.28B | |
| Enterprise value | 9.63B | 22.28B | 6.22B | 14.81B | 8.28B | |
| P/E ratio | 2.49 | -0.28 | -6.41 | 4.61 | 15.43 | |
| Price to sales ratio | 0.49 | 0.38 | 0.52 | 0.4 | 0.98 | |
| POCF ratio | 15.43 | 11.99 | 13.64 | 0 | 17.12 | |
| PFCF ratio | 15.43 | 11.99 | 13.64 | 0 | 17.12 | |
| P/B Ratio | 0.41 | 0.32 | 0 | 0.41 | 0 | |
| PTB ratio | 0.41 | 0.32 | 0 | 0.41 | 0 | |
| EV to sales | 0.68 | 1.66 | 0.52 | 0.9 | 0.98 | |
| Enterprise value over EBITDA | 4.88 | 11.08 | 5.95 | 8.07 | 6.99 | |
| EV to operating cash flow | 21.55 | 52.42 | 13.64 | 0 | 17.12 | |
| EV to free cash flow | 21.55 | 52.42 | 13.64 | 0 | 17.12 | |
| Earnings yield | 0.1 | -0.9 | -0.04 | 0.05 | 0.02 | |
| Free cash flow yield | 0.06 | 0.08 | 0.07 | 0 | 0.06 | |
| Debt to equity | 0 | 1.33 | 0 | 1.1 | 0 | |
| Debt to assets | 0 | 0.42 | 0 | 0.35 | 0 | |
| Net debt to EBITDA | 1.39 | 8.55 | 0 | 4.5 | 0 | |
| Current ratio | 0 | 0.81 | 0 | 0.76 | 0 | |
| Interest coverage | 3.15 | 3.36 | 1.45 | 2.92 | 1.93 | |
| Income quality | 0.65 | -0.09 | -1.88 | 0 | 3.6 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0.02 | 0 | 0.02 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 386.75 | 960.18 | 0 | 268.3 | 0 | |
| ROIC | 0.09 | 0.04 | 0 | 0.03 | 0 | |
| Return on tangible assets | 0 | -0.09 | 0 | 0.01 | 0 | |
| Graham Net | 65.08 | -401.69 | 0 | -357.45 | 0 | |
| Working capital | 2.74B | -4.13B | 0 | -5.56B | 0 | |
| Tangible asset value | 0 | 20.06B | 0 | 20.66B | 0 | |
| Net current asset value | 2.74B | -11.43B | 0 | -11.11B | 0 | |
| Invested capital | 0 | 1.33 | 0 | 1.1 | 0 | |
| Average receivables | 3.66B | 3.93B | 3.93B | 1.34B | 1.34B | |
| Average payables | 2.33B | 2.42B | 2.42B | 2.92B | 2.92B | |
| Average inventory | 2.18B | 1.99B | 1.99B | 1.63B | 1.63B | |
| Days sales outstanding | 0 | 52.86 | 0 | 14.64 | 0 | |
| Days payables outstanding | 0 | 49.98 | 0 | 44.86 | 0 | |
| Days of inventory on hand | 0 | 41.22 | 0 | 25.1 | 0 | |
| Receivables turnover | 0 | 1.7 | 0 | 6.15 | 0 | |
| Payables turnover | 0 | 1.8 | 0 | 2.01 | 0 | |
| Inventory turnover | 0 | 2.18 | 0 | 3.59 | 0 | |
| ROE | 0.04 | -0.29 | 0 | 0.02 | 0 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
ZUARI.NS Frequently Asked Questions
What is Zuari Agro Chemicals Limited stock symbol ?
Zuari Agro Chemicals Limited is a IN stock and trading under the symbol ZUARI.NS
What is Zuari Agro Chemicals Limited stock quote today ?
Zuari Agro Chemicals Limited stock price is $192.3 today.
Is Zuari Agro Chemicals Limited stock public?
Yes, Zuari Agro Chemicals Limited is a publicly traded company.
Something similar
Company Profile
- Volume Average 453.51K
- Market Capitalization 8.45B
- Employee 624
- CEO Mr. Nitin Manguesh Kantak
- Headquarters Bengaluru,IN
- IPO Date 2012-11-27
-
Website
https://www.zuari.in 
Zuari Agro Chemicals Limited engages in the manufacturing, trading, and marketing of chemical fertilizers and other fertilizer products in India. It offers fertilizers, such as urea, DAP, MOP, and other complex fertilizers; water soluble fertilizers; micronutrients, including zinc, boron, etc.; secondary nutrients, including calcium, sulphur, etc.; and organic products, such as compost, humic acid, phosphate rich organic manure, and potash derived from molasses. The company also provides seeds and pesticides. Zuari Agro Chemicals Limited markets its products under the Jai Kisaan brand. The company was formerly known as Zuari Holdings Limited and changed its name to Zuari Agro Chemicals Limited in 2012. Zuari Agro Chemicals Limited was founded in 1967 and is based in Bengaluru, India.
